Province Brands of Canada — the Canadian company developing a suite of premium non-alcoholic, cannabis-powered beers and spirits including the world's first beer brewed from the cannabis plant — has announced the closing of its Series A round of funding with $10.95-million raised by 91 accredited investors.
Australis' Non-Brokered, Over-Subscribed Private Placement Raises $17 Million - Australis Expects to List on the CSE in September 2018
Big pharmaceutical, tobacco, and packaged-goods companies are likely to move into the burgeoning marijuana sector next after initial forays by alcohol companies including Constellation Brands Inc., Molson Coors Brewing Co. and Heineken NV, industry experts said.
Expands Strategic Partnership to Accelerate Canopy Growth's Global Expansion Plans in Rapidly-Growing Medical and Recreational Cannabis Markets
WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) and Phivida Holdings Inc. (CSE:VIDA) (OTC.PHVAF) are pleased to announce the signing of a final definitive joint venture agreement to develop and operate Cannabis Beverages Inc. at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario.
Creates Cannabis Industry's Leading Science Operation; to Deliver Improved Efficiencies and Higher Margin Products and Services
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), today announced financial results for the second quarter ended June 30, 2018.
Empower Clinics Inc. provides investors with a secure cannabis investment option that still allows full participation in this robust U.S. growth potential.
CannTrust Holdings Inc. (TSX: TRST), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation program, today announced financial and operating results for the three and six months ending June 30, 2018.
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Alcanna Inc. (TSX: CLIQ) today announced the companies have reached a license agreement whereby Alcanna has been given exclusive rights to open retail cannabis stores under the brand name "Aurora" across Canada.
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its wholly owned subsidiary, Canopy Health Innovations Inc. is pleased to announce that approval has been received from the Veterinary Drug Directorate of Health Canada to research the effectiveness of cannabidiol to treat anxiety in certain animals.
Vireo Health, Inc., a physician-led medical cannabis company, is pleased to announce that it has completed an initial tranche of a private placement of Series D preferred shares, issuing 357,634 Series D Shares for gross proceeds of US$16,093,545.00.
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is pleased to announce that it has completed the previously announced acquisition of Canopy Health Innovations Inc., including the subsidiary operations of Canopy Animal Health Inc.. The Company believes its strategy of integrating and aligning CHI's clinical platform with the international work of Spectrum Cannabis, will accelerate its comprehensive research programs, build evidence around Canopy products and formulations and ultimately improve patient access to medical cannabis globally.
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it has entered into a letter of intent whereby Aurora intends to acquire the cannabis business of HotHouse Consulting Inc., a provider of advanced greenhouse consulting services.
EVIO Inc., (OTCQB: EVIO), announced today that its Massachusetts laboratory has attained ISO/IEC 17025 accreditation from American Association for Laboratory Accreditation (A2LA). ISO 17025 accreditation is mandatory in Massachusetts for all independent testing laboratories.
